Loading company…
Vita34 offers stem cell banking, collecting and storing umbilical cord blood and tissue, based in Leipzig, Germany.
Founded in Leipzig, Germany, Vita34 provides stem cell banking, including collection, processing and long-term storage of umbilical cord blood and tissue, mainly for families in Germany and neighboring countries. Its revenue comes from collection and processing fees plus annual storage fees. In 2023 it reported revenue of EUR 83,411,504.70 and EBITDA of EUR 5,890,392.30. The company's IPO in March 2007 raised EUR 9 million, which is also its total amount raised, and Süd Beteiligungen has exited its stake.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in